4//SEC Filing
Garanzini Michael 4
Accession 0001144204-18-021207
CIK 0001372514other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 5:24 PM ET
Size
7.1 KB
Accession
0001144204-18-021207
Insider Transaction Report
Form 4
Garanzini Michael
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2018-04-17+156,250→ 171,250 total - Purchase
Warrants (right to buy)
2018-04-17+156,250→ 156,250 totalExercise: $0.32From: 2018-04-17Exp: 2023-04-17→ Common Stock (156,250 underlying)
Footnotes (1)
- [F1]The reported securities were purchased by the reporting person for a combined purchase price of $0.32 per share of common stock and warrant in connection with the Issuer's public offering that closed on April 17, 2018. Each warrant will be exercisable during the period commencing on April 17, 2018 and ending on April 17, 2023 at an exercise price of $0.32.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001722844
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 5:24 PM ET
- Size
- 7.1 KB